The Impact of Ozempic and Wegovy on Food Choices
Drugs like Ozempic and Wegovy have transformed the lives of many by aiding weight loss without resorting to surgery. However, their influence extends beyond just weight—these medications are also reshaping consumers’ shopping habits and overall spending.
Understanding the Study
A recent study from Denmark, published in JAMA Network Open, sheds light on this phenomenon. While past understanding of GLP-1 users’ diets relied heavily on self-reported data, which can often be unreliable, this research takes an objective approach by analyzing actual purchase receipts.
The Research Methodology
Led by Kathrine Kold Sørensen from Copenhagen University Hospital, the team scrutinized over 2 million transactions from 1,177 participants. By comparing receipts from before and after the medications were introduced, they identified significant shifts in consumer behavior.
Findings: A Shift in Shopping Habits
The results revealed a marked decrease in the purchase of ultra-processed foods, dropping from 39.2% to 38%. In contrast, a control group not taking the medication saw an increase in ultra-processed food consumption. This shift also resulted in a rise in purchases of whole, nutritious foods, climbing from 46.9% to 47.8%.
Additionally, there was a noticeable decrease in calories purchased per 100 grams, with reduced sugar, saturated fats, and carbohydrates, while protein purchases increased.
Economic Implications of Healthier Choices
Further reports, including a December 2025 study from Cornell University using data from Numerator, indicated an immediate financial impact. Households using Ozempic reported a 5.5% reduction in supermarket spending. Items like salty snacks and sweets saw declines of between 10% and 11%, while purchases of healthier alternatives such as yogurts, fresh fruit, and protein bars experienced a slight boost.
The Psychological Mechanism Behind Behavioral Changes
This transformation isn’t just about willpower. Experts like Cristóbal Morales and Joana Nicolau emphasize that the drugs influence the brain’s reward system. Animal studies suggest that, under the effects of GLP-1, preferences for fatty and sugary foods diminish, translating to humans losing the impulse to reach for unhealthy snacks.
The Caveats: Temporary Changes
Despite these positive shifts, not all news is favorable. Discontinuation of the medication can lead to a reversal of purchasing behaviors, indicating that lasting change may be temporary and heavily reliant on ongoing treatment. Additionally, the observational nature of the study raises questions about potential biases, as participants willing to share their receipts may be more health-conscious.
Conclusion
In summary, medications like Ozempic and Wegovy are not only aiding in weight loss but are also fostering healthier shopping patterns and reducing expenditures on unhealthy snacks. Their physiological effects on the brain play a crucial role in diminishing cravings for high-calorie processed foods. However, the sustainability of these changes remains in question, emphasizing the need for ongoing support beyond pharmacological interventions.